Research Update End-Year 3 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk

End-year 3 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.

CHF-01918G-Bryan-Cancer-EY3-Summary.pdf

Comments are closed.